Leon Niezen and Gert Desmet describe how predictive uncertainty can make automated LC method development more reliable.
Liquid chromatography–tandem mass spectrometry (LC–MS/MS) reveals distinct sphingolipid patterns in anorexia and obesity.
Liquid chromatography–mass spectrometry (LC–MS) serum profiling ties lysine compounds to lupus kidney disease.
Liquid chromatography–tandem mass spectrometry (LC–MS/MS) measures galactose-1-phosphate in dried blood spots to monitor galactosemia.
Dual-column ultra-high-performance liquid chromatography-mass spectrometry (UHPLC-MS) reveals urine markers of apple intake lasting 24 hours.
Directive (EU) 2024/3019 makes drug manufacturers financially responsible for removing pharmaceutical residues from wastewater and introduces stricter, standardized monitoring requirements that are ...
At HTC-19 in Leuven, Belgium, Viktoriia Turkina (University of Amsterdam) discussed her group’s strategy for prioritizing ...
AOA Dx Chief Scientific Officer Abby McElhinny discusses with LCGC International how the company used high-resolution mass spectrometry-based multi-omics to develop Omira OC, a targeted blood test for ...
PFAS, pyrolysis oils, new GC hardware, and AI in the laboratory led the program at the 2026 Gulf Coast Conference in ...
LCGC International provides separation science insights, including liquid chromatography (HPLC), gas chromatography (GC), and ...
Liquid chromatography–tandem mass spectrometry (LC–MS/MS) shows how processing and storage shape toxins in Nigerian rice.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results